Get the Stockscreener App
4.01
1.47%
-0.06
Shattuck Labs Inc stock is traded at $4.01, with a volume of 271.06K.
It is down -1.47% in the last 24 hours and down -7.60% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$4.07
Open:
$4
24h Volume:
271.06K
Relative Volume:
0.52
Market Cap:
$253.75M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-2.0777
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
+3.89%
1M Performance:
-7.60%
6M Performance:
+297.03%
1Y Performance:
+210.85%
1-Day Range:
$3.97
$4.20
1-Week Range:
$3.83
$4.22
52-Week Range:
$0.6922
$4.89
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
4.01 | 257.55M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.90 | 119.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.67 | 82.71B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
844.41 | 52.43B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
336.19 | 45.01B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
362.14 | 39.23B | 4.98B | 69.60M | 525.67M | 0.5198 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-26 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-08-25 | Initiated | Wedbush | Outperform |
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Shattuck Labs Just Shocked Wall Street: Is STTK the Next Sleeper Biotech Rocket or Total Trap? - AD HOC NEWS
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $6.20 Average Price Target from Analysts - Defense World
Market Recap: Is Shattuck Labs Inc. stock positioned well for digital economyCEO Change & Smart Money Movement Tracker - mfd.ru
Can Shattuck Labs Inc. deliver consistent dividendsPortfolio Return Summary & Free Expert Approved Momentum Trade Ideas - mfd.ru
What’s the RSI of Shattuck Labs Inc. stockTrade Exit Summary & Real-Time Volume Analysis - mfd.ru
What is the cash position of Shattuck Labs Inc.July 2025 Weekly Recap & Weekly High Momentum Picks - mfd.ru
Shattuck Labs, Inc. (NASDAQ:STTK) Given Average Rating of "Hold" by Brokerages - MarketBeat
Why is Shattuck Labs Inc. stock going downTrade Entry Summary & Fast Momentum Entry Tips - mfd.ru
Is Shattuck Labs Inc.’s ROIC above industry averageQuarterly Portfolio Review & Weekly Top Gainers Trade List - mfd.ru
Fed Watch: Will Shattuck Labs Inc benefit from green energy policiesEarnings Miss & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium - marketscreener.com
Breakout Zone: Why is Shattuck Labs Inc stock going downAnalyst Downgrade & Advanced Technical Analysis Signals - baoquankhu1.vn
Shattuck Labs to Participate in Immunology Symposium - Intellectia AI
Inside Shattuck Labs' Piper Sandler immunology fireside chat - stocktitan.net
Shattuck Labs Insider Buyers Net US$637k Despite 12% Stock Decline - simplywall.st
Shattuck Labs Sets Earlier Date for 2026 Annual Meeting - TipRanks
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Shattuck Labs (STTK) Price Target Increased by 55.36% to 7.40 - Nasdaq
Shattuck Labs, Inc. (NASDAQ:STTK) Sees Significant Increase in Short Interest - MarketBeat
Piper Sandler Initiates Coverage of Shattuck Labs (STTK) with Overweight Recommendation - Nasdaq
Piper Sandler Initiates Coverage on STTK with Overweight Rating - GuruFocus
Shattuck earns new Overweight at Piper Sandler ahead of upcoming catalysts - Seeking Alpha
Piper Sandler Initiates Coverage on Shattuck Labs With Overweight Rating, $15 Price Target - marketscreener.com
Shattuck Labs initiated with an Overweight at Piper Sandler - TipRanks
Piper Sandler initiates Shattuck Labs stock with Overweight rating By Investing.com - Investing.com Canada
Will DAKT stock hit new highs in YEAR2025 Market WrapUp & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Shattuck Labs Launches $75 Million At-The-Market Offering - TipRanks
Shattuck Labs Inc enters $75 million common stock sales agreement with Leerink Partners - marketscreener.com
Earnings Risk: Why is Shattuck Labs Inc stock going downJuly 2025 Setups & Daily Profit Focused Stock Screening - baoquankhu1.vn
Is Shattuck Labs Inc.’s growth already priced inJuly 2025 Setups & Growth Oriented Trade Recommendations - bollywoodhelpline.com
Resistance Check: Is Shattuck Labs Inc stock a value trapQuarterly Trade Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Update - Defense World
Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK) - Seeking Alpha
Shattuck Labs (STTK) Price Target Increased by 16.67% to 4.76 - Nasdaq
Shattuck Labs Files $200 Million Mixed Shelf - marketscreener.com
Pullback Watch: Why is Comtech Telecommunications Corp stock going upWeekly Trading Summary & Community Consensus Trade Alerts - baoquankhu1.vn
CEO Change: How Shattuck Labs Inc stock reacts to Fed rate cuts2025 Risk Factors & Long Hold Capital Preservation Plans - Bộ Nội Vụ
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
How interest rate cuts could boost Shattuck Labs Inc. stockEarnings Performance Report & Free Technical Confirmation Trade Alerts - ulpravda.ru
Will Shattuck Labs Inc. stock gain from lower inflationLong Run Comfort Guide & lightweight options for faster days - Улправда
How Shattuck Labs Inc. stock reacts to global recession fearsJuly 2025 Final Week & AI Enhanced Execution Alerts - Улправда
Can Shattuck Labs Inc. stock attract ESG capital inflowsWeekly Gains Report & Stepwise Entry and Exit Trade Signals - Улправда
Is Shattuck Labs Inc. stock a top pick in earnings seasonBull Run & Weekly Stock Breakout Alerts - Улправда
Individual Investors Are Shattuck Labs, Inc.'s (NASDAQ:STTK) Biggest Owners and Were Rewarded After Market Cap Rose by US$73m Last Week - 富途牛牛
Shattuck Labs (NASDAQ:STTK) Trading 20.6% HigherTime to Buy? - MarketBeat
Shattuck Labs (NASDAQ:STTK) Trading 20.6% Higher – Time to Buy? - Defense World
Does Shattuck Labs Inc. stock trade at a discount to peersRisk Adjusted Returns & You’ve Never Seen Stock Picks Like These - Улправда
Why Shattuck Labs stock soared in December - MSN
Why Madrigal Pharmaceuticals Stock Slumped on Tuesday - AOL.com
Shattuck Labs (STTK): Citigroup Maintains Neutral Rating, Raises Price Target | STTK Stock News - GuruFocus
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):